Cite
Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensus.
MLA
Kishnani, Priya S., et al. “Screening, Patient Identification, Evaluation, and Treatment in Patients with Gaucher Disease: Results from a Delphi Consensus.” Molecular Genetics & Metabolism, vol. 135, no. 2, Feb. 2022, pp. 154–62. EBSCOhost, https://doi.org/10.1016/j.ymgme.2021.12.009.
APA
Kishnani, P. S., Al-Hertani, W., Balwani, M., Göker-Alpan, Ö., Lau, H. A., Wasserstein, M., Weinreb, N. J., & Grabowski, G. (2022). Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensus. Molecular Genetics & Metabolism, 135(2), 154–162. https://doi.org/10.1016/j.ymgme.2021.12.009
Chicago
Kishnani, Priya S., Walla Al-Hertani, Manisha Balwani, Özlem Göker-Alpan, Heather A. Lau, Melissa Wasserstein, Neal J. Weinreb, and Gregory Grabowski. 2022. “Screening, Patient Identification, Evaluation, and Treatment in Patients with Gaucher Disease: Results from a Delphi Consensus.” Molecular Genetics & Metabolism 135 (2): 154–62. doi:10.1016/j.ymgme.2021.12.009.